data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Amicus Therapeutics
(NASDAQ:FOLD)
$10.80
0.06[0.56%]
At close: Jul 1
$10.72
-0.0800[-0.74%]
After Hours: 7:43PM EDT
Day High/Low10.56 - 10.97
52 Week High/Low5.91 - 12.63
Open / Close10.7 / 10.8
Float / Outstanding278.6M / 280.2M
Vol / Avg.3.8M / 4.1M
Mkt Cap3B
P/E-
50d Avg. Price8.16
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float278.6M

Amicus Therapeutics (NASDAQ:FOLD), Quotes and News Summary

Amicus Therapeutics (NASDAQ: FOLD)

Day High/Low10.56 - 10.97
52 Week High/Low5.91 - 12.63
Open / Close10.7 / 10.8
Float / Outstanding278.6M / 280.2M
Vol / Avg.3.8M / 4.1M
Mkt Cap3B
P/E-
50d Avg. Price8.16
Div / Yield-
Payout Ratio-
EPS-0.3
Total Float278.6M
Benzinga - Jun 22, 2022, 10:17AM
Benzinga - May 10, 2022, 5:18PM
Benzinga - May 10, 2022, 4:23PM
Benzinga - May 9, 2022, 7:05AM
Benzinga - May 9, 2022, 7:04AM
Benzinga - Apr 19, 2022, 7:13AM
Benzinga - Mar 16, 2022, 10:02AM
Benzinga - Mar 16, 2022, 7:12AM
Benzinga - Feb 24, 2022, 1:16PM
Benzinga - Feb 24, 2022, 10:03AM
Benzinga - Feb 24, 2022, 7:19AM
Benzinga - Feb 24, 2022, 7:03AM
Benzinga - Feb 8, 2022, 7:41AM
Benzinga - Jan 14, 2022, 10:52AM
Benzinga - Jan 14, 2022, 5:05AM
Benzinga - Jan 13, 2022, 7:27AM
Benzinga - Jan 10, 2022, 2:05PM
load more
Sector: Health Care.Industry: Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.250-0.300 -0.0500
REV77.130M78.715M1.585M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Amicus Therapeutics Questions & Answers

Q
How do I buy Amicus Therapeutics (FOLD) stock?
A

You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Amicus Therapeutics's (FOLD) competitors?
Q
What is the target price for Amicus Therapeutics (FOLD) stock?
A

The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by SVB Leerink on Thursday, February 24, 2022. The analyst firm set a price target for 14.00 expecting FOLD to rise to within 12 months (a possible 29.63% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Amicus Therapeutics (FOLD)?
A

The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $10.8 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Amicus Therapeutics (FOLD) pay a dividend?
A

There are no upcoming dividends for Amicus Therapeutics.

Q
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
A

Amicus Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Amicus Therapeutics (FOLD) going to split?
A

There is no upcoming split for Amicus Therapeutics.

Q
What sector and industry does Amicus Therapeutics (FOLD) operate in?
A

Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.